@article{4b9a74dcb1a74e5e897cb61e8678e48a,
title = "Patients at high risk of suicide before and during a COVID-19 lockdown: Ecological momentary assessment study",
abstract = "The coronavirus disease 2019 (COVID-19) outbreak may have affected the mental health of patients at high risk of suicide. In this study we explored the wish to die and other suicide risk factors using smartphone-based ecological momentary assessment (EMA) in patients with a history of suicidal thoughts and behaviour. Contrary to our expectations we found a decrease in the wish to die during lockdown. This is consistent with previous studies showing that suicide rates decrease during periods of social emergency. Smartphone-based EMA can allow us to remotely assess patients and overcome the physical barriers imposed by lockdown.",
keywords = "COVID-19, Suicide, ecological momentary assessment, machine learning, suicide attempt",
author = "Aurora Cobo and Alejandro Porras-Segovia and P{\'e}rez-Rodr{\'i}guez, {Mari{\'a} Mercedes} and Antonio Art{\'e}s-Rodr{\'i}guez and Barrig{\'o}n, {Maria Luisa} and Philippe Courtet and Enrique Baca-Garci{\'a}",
note = "Funding Information: This study received grant support from Instituto de Salud Carlos III (ISCIII PI13/02200; PI16/01852; CM19/00026), Delegaci{\'o}n del Gobierno para el Plan Nacional de Drogas (20151073), the American Foundation for Suicide Prevention (LSRG-1-005-16), the Ministerio de Ciencia, Innovaci{\'o}n y Universidades (RTI2018-099655-B-I00; TEC2017-92552-EXP), and by the Comunidad de Madrid (Y2018/TCS-4705, PRACTICO-CM). Funding Information: E.B.G. has been a consultant to or has received honoraria from Janssen Cilag, Lundbeck, Otsuka, Pziffer, Servier and Sanoffi. E.B.-G. and A.A.-R. designed the MEmind application. M.M.P.-R. has received research grant funding from Neurocrine Biosciences (Inc), Millennium Pharmaceuticals, Takeda, Merck, and AI Cure; she is an advisory board member for Neurocrine Biosciences, Inc, and a consultant on an American Foundation for Suicide Prevention (AFSP) grant (LSRG-1-005-16, PI: E.B.-G.). Funding Information: This study received grant support from Instituto de Salud Carlos III (ISCIII PI13/02200; PI16/01852; CM19/00026), Delegaci?n del Gobierno para el Plan Nacional de Drogas (20151073), the American Foundation for Suicide Prevention (LSRG-1-005-16), the Ministerio de Ciencia, Innovaci?n y Universidades (RTI2018-099655-B-I00; TEC2017-92552-EXP) and by the Comunidad de Madrid (Y2018/TCS-4705, PRACTICO-CM). Funding Information: This study received grant support from Instituto de Salud Carlos III (ISCIII PI13/02200; PI16/01852; CM19/00026), Delegaci{\'o}n del Gobierno para el Plan Nacional de Drogas (20151073), the American Foundation for Suicide Prevention (LSRG-1-005-16), the Ministerio de Ciencia, Innovaci{\'o}n y Universidades (RTI2018-099655-B-I00; TEC2017-92552-EXP) and by the Comunidad de Madrid (Y2018/TCS-4705, PRACTICO-CM). Publisher Copyright: Copyright {\textcopyright} The Author(s), 2021. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists.",
year = "2021",
doi = "10.1192/bjo.2021.43",
language = "English",
volume = "7",
journal = "BJPsych Open",
issn = "2056-4724",
publisher = "Cambridge University Press",
number = "3",
}